BMC Highlights for World Cancer Day
Published in Cancer
Cancer is a devastating disease where cells accumulate genetic mutations and become able to proliferate uncontrollably and abnormally. As the groups of abnormal cells grow, they consume copious amounts of resources and can alter their surroundings for their benefit through complicated signalling processes. A highly adaptive disease that can occur in any tissue, it is difficult to treat.
Cancer in hominins dates back 1.7 million years. Discovered by archaeologists was an osteosarcoma on a fossilised toe. Since then, the devastating disease has been studied by scholars, artists and medical professionals throughout the ages. Many treatments have been proposed and tried, from cauterisation to application of arsenic paste, while surgery remained a risky option without proper antiseptic conditions and anaesthesia. It is an ever-evolving disease, highly adaptive and costly to treat. In the current age, scientists are still discovering new aspects of cancer, establishing new pathways, causes and proposing new treatment targets.
In recognition of World Cancer Day in February, we highlight interesting manuscripts or collection topics related to cancer. World Cancer Day was named to raise awareness of the disease, as well as encourage discussion of its pathogenesis, epidemiology, treatment options and field advancements. With an estimated 20 million new cases worldwide each year and 48% mortality, cancer remains one of the most challenging diseases to treat.
Highlighted collection topics are soon to open in the journals BMC Pulmonary Medicine “Cancer and the lung” and BMC Cardiovascular Disorders “Cancer and cardiovascular disorders”. These collections seek manuscripts relating to molecular mechanisms, advances in imaging and therapeutic techniques, complications of disease or chemotherapy, and management.
In BMC Oral Health edited by Alex Goodridge, the collection “Oral complications from cancer treatment” is open for submissions until 5th June 2025, exploring complications resulting from cancer treatments, including mucositis, xerostomia, and osteonecrosis., inviting manuscripts on the mechanisms, management strategies, and innovative therapies. “Early detection and prevention of oral cancer” is now closed and published, with an interesting array of manuscripts on dental, medical, and epidemiological research that will assist clinicians and decision-makers in identifying effective strategies to prevent oral cancer, as well as detecting the disease in at-risk populations.
In BMC Gastroenterology edited by Harshal Dhondge, two collections “GI cancer risk assessment” (open until 21st March 2025) and “Pancreatitis and pancreatic cancer” (open until 7th May 2025) are currently open for submissions. “GI cancer risk assessment” invites submissions relating to molecular pathways, imaging modalities, autoimmune and gallstone pancreatitis management, pancreatic cancer biomarkers, microbiota and pancreatic diseases, and therapeutic approaches for pancreatic insufficiency and alcohol-induced pancreatitis. “Pancreatitis and pancreatic cancer” inviting submissions that explore novel approaches to risk assessment, screening, and surveillance, with the aim of advancing personalized strategies for early detection and prevention of gastrointestinal (GI) cancers.
There have also been interesting highlighted manuscripts published across the BMC series. In BMC Pediatrics edited by Jieying Zhou, a study investigates how peri-interventional reduction of pain, anxiety and distress using virtual reality can help children with cancer cope with stressful and painful interventions.
In BMC Oral Health edited by Alex Goodridge, studies explore how oral rinses containing the tumorigenic biomarker CD44 can help high-risk individuals such as smokers detect cancer early. A differently-focused study explores betel nut chewing dependence and the associated risks and socioeconomic factors that drive it.
In BMC Genomics edited by Sophie Nicod, a new app called Sherlock-Genome has been developed for the effective integrative analysis of whole genome sequencing studies and to drive discovery and research advancements. Another seeks to find a good reference gene in hypoxia-driven breast cancer progression using reverse transcription-quantitative real-time polymerase chain reaction (RT-qPCR).
Finally, in BMC Medical Informatics and Decision Making and BMC Medical Research Methodology edited by Piero Lo Monaco, one study explores the importance of tailoring medical decision making processes and individual patient preferences to enhance cancer patient care. A different paper reviews artificial intelligence models by applying them to longitudinal data for the prediction of cancer.
Xiulin joined Springer Nature as an Associate Editor in 2024. She holds a PhD in Biology from the Albert Ludwig University of Freiburg, Germany and a master’s degree in Clinical Neuroscience from the Institute of Neurology at University College London (UCL), UK. She has a broad background in the biomedical sciences, with her master’s degree research focused on mitochondrial dysfunction in multiple sclerosis, and her PhD research on apoptotic molecular mechanisms in cancer. She is motivated to be part of Open Access scientific publishing and believes it paves the way for sharing accessible sound science and knowledge.
Xiulin currently co-chairs the Cardiovascular Research Community. She is an active member of several SDG Working Groups at Springer Nature, and raises awareness for the SDGs through various projects. She recently launched an SDG 1-SDG 3 collaboration project on the challenges associated with universal health coverage.
Follow the Topic
-
BMC Cardiovascular Disorders
This journal is an open access, peer-reviewed journal that considers articles on the characterization, prevention, diagnosis and treatment of disorders of the heart and circulatory system.
-
BMC Pulmonary Medicine
This journal is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of pulmonary and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
-
BMC Gastroenterology
This is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of gastrointestinal and hepatobiliary disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
-
BMC Oral Health
This is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of disorders of the mouth, teeth and gums, as well as related molecular genetics, pathophysiology, and epidemiology.
-
BMC Pediatrics
This is an open access journal publishing peer-reviewed research articles in all aspects of health care in neonates, children and adolescents, as well as related molecular genetics, pathophysiology, and epidemiology.
-
BMC Medical Research Methodology
This is an open access, peer-reviewed journal publishing original research articles in methodological approaches to healthcare research.
-
BMC Genomics
This is an open access, peer-reviewed journal that considers articles on all aspects of genetics, genomics and proteomics.
-
BMC Medical Informatics and Decision Making
This is an open access journal publishing original peer-reviewed research articles in relation to the design, development, implementation, use, and evaluation of health information technologies and decision-making for human health.
Related Collections
With Collections, you can get published faster and increase your visibility.
Advances in crop omics
The field of crop omics has rapidly evolved over the past decade, integrating genomics, transcriptomics, and other high-throughput technologies to enhance our understanding of plant biology. This Collection aims to showcase innovative research that leverages these advanced methodologies to explore the genetic and molecular underpinnings of crop traits, including yield, stress resistance, and disease susceptibility. By employing techniques such as RNA-Seq and genome sequencing, the complexities of crop genomes and their interactions with the environment can be revealed, leading to the development of improved cultivars.
Advances in crop omics play a crucial role in addressing global challenges such as food security and climate change. Recent breakthroughs in genomic editing and high-throughput sequencing technologies have enabled the rapid identification of beneficial traits in crops, allowing for more efficient breeding programs. For instance, CRISPR/Cas9 technology has been utilized to develop rice varieties with enhanced resistance to bacterial blight by precisely editing genes associated with disease susceptibility, thereby improving the plant's natural defense mechanisms. Additionally, Next-Generation Sequencing (NGS) has been used to identify single nucleotide polymorphisms (SNPs) linked to drought tolerance in crops, facilitating the development of crop varieties that can thrive in water-scarce environments. These innovations not only enhance crop resilience and productivity but also contribute to sustainable agricultural practices, thereby supporting the need for research that aligns with environmental and socio-economic goals.
Continued exploration in this field promises exciting developments, including the integration of artificial intelligence and machine learning for predictive modeling of crop performance. As researchers study the functional genomics of crops, precision agriculture techniques may emerge to optimize resource use and minimize environmental impact. The potential to develop crops that thrive under varying climatic conditions could revolutionize agricultural practices and ensure food security for future generations.
Topics of interest include, but are not limited to:
- Genomic approaches to crop improvement
- RNA-Seq applications in crop research
- Functional genomics of disease resistance
- Sustainable practices through omics technologies
- Metabolomics and its role in crop trait enhancement
- Epigenetic modifications and their impact on crop development
- The role of microbiomes in crop health and productivity
- Genetic diversity assessment through high-throughput sequencing
- The use of CRISPR technology in targeted trait enhancement
- Machine learning applications in crop phenotype prediction
This Collection supports and amplifies research related to SDG 2: Zero Hunger.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Nov 20, 2026
Omics of parasites 2026
Parasites, ranging from bacteria to multicellular eukaryotes, exhibit sophisticated life cycles and develop complex interactions with their hosts. The development and application of high-throughput omics techniques enabling simultaneous analysis of virtually all genes, transcripts, and proteins has greatly facilitated research in parasite biology. At the dawn of the sequencing era, the sequencing of parasites’ genomes led to the identification of numerous novel virulence factors and potential drug targets. Nowadays, multi-omics approaches are becoming instrumental for pinpointing molecules and pathways involved in parasite development and its complex network of interactions with the host.
For this BMC Genomics Collection, we welcome submissions generating or analyzing omics data (including, but not limited to, genomic, transcriptomic, proteomic, and metabolomic data) or combining them to shed light on parasites’ biology and the molecular basis of host-parasite interactions. The scope of this Collection is wide and submissions on any kind of parasites are welcome.
If you have a data note to submit, please submit to our sister collection Omics of parasites data notes in BMC Genomic Data.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Dec 15, 2026
